163 related articles for article (PubMed ID: 35627129)
1. The Role of Functional Polymorphisms in the Extracellular Matrix Modulation-Related Genes on Dupuytren's Contracture.
Samulenas G; Insodaite R; Kunceviciene E; Poceviciute R; Masionyte L; Zitkeviciute U; Pilipaityte L; Smalinskiene A
Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627129
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of WNT Signaling Pathway Gene Variants
Samulėnas G; Smalinskienė A; Rimdeika R; Braziulis K; Fomkinas M; Paškevičius R
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573275
[TBL] [Abstract][Full Text] [Related]
3. A common SNP risk variant MT1-MMP causative for Dupuytren's disease has a specific defect in collagenolytic activity.
Itoh Y; Ng M; Wiberg A; Inoue K; Hirata N; Paiva KBS; Ito N; Dzobo K; Sato N; Gifford V; Fujita Y; Inada M; Furniss D
Matrix Biol; 2021 Mar; 97():20-39. PubMed ID: 33592276
[TBL] [Abstract][Full Text] [Related]
4. Genetic susceptibility in Dupuytren's disease. TGF-beta1 polymorphisms and Dupuytren's disease.
Bayat A; Watson JS; Stanley JK; Alansari A; Shah M; Ferguson MW; Ollier WE
J Bone Joint Surg Br; 2002 Mar; 84(2):211-5. PubMed ID: 11924651
[TBL] [Abstract][Full Text] [Related]
5. Common variants of the EPDR1 gene and the risk of Dupuytren’s disease.
Dębniak T; Żyluk A; Puchalski P; Serrano-Fernandez P
Handchir Mikrochir Plast Chir; 2013 Oct; 45(5):253-7. PubMed ID: 24089297
[TBL] [Abstract][Full Text] [Related]
6. SNPs previously associated with Dupuytren's disease replicated in a North American cohort.
Anderson ER; Ye Z; Caldwell MD; Burmester JK
Clin Med Res; 2014 Dec; 12(3-4):133-7. PubMed ID: 24573701
[TBL] [Abstract][Full Text] [Related]
7. DNA copy number variations at chromosome 7p14.1 and chromosome 14q11.2 are associated with dupuytren's disease: potential role for MMP and Wnt signaling pathway.
Shih B; Tassabehji M; Watson JS; Bayat A
Plast Reconstr Surg; 2012 Apr; 129(4):921-932. PubMed ID: 22183494
[TBL] [Abstract][Full Text] [Related]
8. Wnt signaling and Dupuytren's disease.
Dolmans GH; Werker PM; Hennies HC; Furniss D; Festen EA; Franke L; Becker K; van der Vlies P; Wolffenbuttel BH; Tinschert S; Toliat MR; Nothnagel M; Franke A; Klopp N; Wichmann HE; Nürnberg P; Giele H; Ophoff RA; Wijmenga C; ; ; ;
N Engl J Med; 2011 Jul; 365(4):307-17. PubMed ID: 21732829
[TBL] [Abstract][Full Text] [Related]
9. Dupuytren's Contracture: Incidence of Injury-Induced Cases and Specific Clinical Expression.
Samulėnas G; Rimdeika R; Braziulis K; Fomkinas M; Paškevičius R
Medicina (Kaunas); 2020 Jun; 56(7):. PubMed ID: 32629785
[No Abstract] [Full Text] [Related]
10. Genetic susceptibility to Dupuytren's disease: transforming growth factor beta receptor (TGFbetaR) gene polymorphisms and Dupuytren's disease.
Bayat A; Stanley JK; Watson JS; Ferguson MW; Ollier WE
Br J Plast Surg; 2003 Jun; 56(4):328-33. PubMed ID: 12873459
[TBL] [Abstract][Full Text] [Related]
11. Genetic susceptibility in Dupuytren's disease: lack of association of a novel transforming growth factor beta(2) polymorphism in Dupuytren's disease.
Bayat A; Alansar A; Hajeer AH; Shah M; Watson JS; Stanley JK; Ferguson MW; Ollier WE
J Hand Surg Br; 2002 Feb; 27(1):47-9. PubMed ID: 11895345
[TBL] [Abstract][Full Text] [Related]
12. A Weighted Genetic Risk Score Predicts Surgical Recurrence Independent of High-Risk Clinical Features in Dupuytren's Disease.
Riesmeijer SA; Manley OWG; Ng M; Nolte IM; Broekstra DC; Werker PMN; Furniss D
Plast Reconstr Surg; 2019 Feb; 143(2):512-518. PubMed ID: 30688894
[TBL] [Abstract][Full Text] [Related]
13. Common variants of the ALDH2 and DHDH genes and the risk of Dupuytren's disease.
Zyluk A; Debniak T; Puchalski P
J Hand Surg Eur Vol; 2013 May; 38(4):430-4. PubMed ID: 23303836
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase 8 (MMP8) gene polymorphisms in chronic periodontitis.
Izakovicova Holla L; Hrdlickova B; Vokurka J; Fassmann A
Arch Oral Biol; 2012 Feb; 57(2):188-96. PubMed ID: 21920499
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
Ulrich D; Hrynyschyn K; Pallua N
Plast Reconstr Surg; 2003 Oct; 112(5):1279-86. PubMed ID: 14504511
[TBL] [Abstract][Full Text] [Related]
16. Dupuytren's disease susceptibility gene, EPDR1, is involved in myofibroblast contractility.
Staats KA; Wu T; Gan BS; O'Gorman DB; Ophoff RA
J Dermatol Sci; 2016 Aug; 83(2):131-7. PubMed ID: 27245865
[TBL] [Abstract][Full Text] [Related]
17. Involvement of pro-inflammatory cytokines and growth factors in the pathogenesis of Dupuytren's contracture: a novel target for a possible future therapeutic strategy?
Bianchi E; Taurone S; Bardella L; Signore A; Pompili E; Sessa V; Chiappetta C; Fumagalli L; Di Gioia C; Pastore FS; Scarpa S; Artico M
Clin Sci (Lond); 2015 Oct; 129(8):711-20. PubMed ID: 26201022
[TBL] [Abstract][Full Text] [Related]
18. Dupuytren's contracture-associated SNPs increase SFRP4 expression in non-immune cells including fibroblasts to enhance inflammation development.
Kida H; Jiang JJ; Matsui Y; Takahashi I; Hasebe R; Kawamura D; Endo T; Shibayama H; Kondo M; Nishio Y; Nishida K; Matsuno Y; Oikawa T; Kubota SI; Hojyo S; Iwasaki N; Hashimoto S; Tanaka Y; Murakami M
Int Immunol; 2023 Jul; 35(7):303-312. PubMed ID: 36719100
[TBL] [Abstract][Full Text] [Related]
19. Abnormal growth factor and cytokine expression in Dupuytren's contracture.
Baird KS; Crossan JF; Ralston SH
J Clin Pathol; 1993 May; 46(5):425-8. PubMed ID: 8320323
[TBL] [Abstract][Full Text] [Related]
20. Association Between
Insodaite R; Liutkevicius V; Uloza V; Solovejute R; Smalinskiene A
Anticancer Res; 2020 Apr; 40(4):2003-2009. PubMed ID: 32234890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
